|
MediWatch
Ltd was founded by Philip Stimpson
in 1996, to develop medical
products for the point-of-care
environment. Initially, the
Company focused on the Primary
Care market and developed a
few niche diagnostic products
for urology. In October 2000,
Mediwatch successfully listed
on the AIM with the reverse
take-over of Prostcare Plc.
Mediwatch Plc raised in excess
of £6 million for research
and a “systems approach” to
product development. In December
2006, Mediwatch Plc successfully
completed an agreement to purchase
stock and license certain intellectual
property from the urology diagnostics
division of Medtronic A/S.
This acquisition brought the
benefit of a global footprint
distribution network.
|
|
Mediwatch
Plc has won four prestigious
Research and Technology awards
for innovation from the British
and European governments.
Mediwatch Plc has approvals
in ISO13485, CE, CMDCAS and
FDA..
|
|
